RGNX
Regenxbio Inc
7.50$
-8.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.66 | 0.50 | 0.34 | 0.44 | 0.48 | 0.42 | 1.73 | 0.41 | 0.58 | 0.59 | 0.12 | 2.04 | 3.29 | |
| 0.28 | 0.35 | 0.19 | 0.29 | 0.24 | 0.12 | 0.07 | 0.18 | 1.20 | 0.11 | 0.21 | 0.02 | 1.51 | |
| 0.38 | 0.15 | 0.16 | 0.15 | 0.23 | 0.29 | 1.66 | 0.24 | -0.62 | 0.47 | -0.09 | 2.02 | 1.78 | |
| 1.32 | 1.17 | 1.11 | 0.89 | 1.07 | 0.99 | 1.03 | 1.08 | 1.09 | 1.15 | 1.09 | 1.06 | 4.32 | |
| 0.53 | 0.43 | 0.40 | 0.37 | 0.38 | 0.39 | 0.40 | 0.39 | 0.39 | 0.43 | 0.41 | 0.41 | 1.61 | |
| 1.85 | 1.60 | 1.51 | 1.26 | 1.45 | 1.30 | 1.43 | 1.47 | 0.39 | 1.59 | 1.50 | 1.47 | 4.88 | |
| -1.48 | -1.45 | -1.35 | -1.11 | -1.22 | -1.01 | 0.24 | -1.23 | -1.01 | -1.11 | -1.59 | 0.55 | -3.10 | |
| 0.04 | 0.03 | 0.04 | 0.01 | 0.02 | 0.19 | 0.17 | 0.21 | 0.25 | 0.24 | 0.17 | 0.15 | 0.79 | |
| -1.41 | -1.43 | -1.38 | -1.05 | -1.17 | -1.01 | 0.12 | -1.38 | -1.20 | -1.30 | -1.72 | 0.43 | -3.71 | |
| -0.06 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | – | – | |
| -1.41 | -1.43 | -1.38 | -1.05 | -1.17 | -1.01 | 0.12 | -1.38 | -1.20 | -1.30 | -1.72 | 0.43 | -3.71 | |
| -1.27 | -1.30 | -1.25 | -0.96 | -1.08 | -0.74 | 0.36 | -1.09 | -0.87 | -0.99 | -1.48 | 0.65 | -2.62 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.